K

Kyntra Bio Inc
D

KYNB

6.90900
USD
-0.01
(-0.16%)
مغلق
حجم التداول
19
الربح لكل سهم
-15
العائد الربحي
-
P/E
-0
حجم السوق
27,968,406
المقالات
المزيد

العنوان: Kyntra Bio Inc

القطاع: Healthcare
الصناعة: Biotechnology
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.